gabexate has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, N | 1 |
| Kawata, S | 1 |
| Tamura, S | 1 |
| Kiso, S | 1 |
| Tsushima, H | 1 |
| Maeda, Y | 1 |
| Yamasaki, E | 1 |
| Igura, T | 1 |
| Matsuzawa, Y | 1 |
1 other study available for gabexate and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Induction of interleukin-6 by interferon alfa and its abrogation by a serine protease inhibitor in patients with chronic hepatitis C.
Topics: 2',5'-Oligoadenylate Synthetase; Adult; Aged; Base Sequence; Chronic Disease; Female; Gabexate; Hepa | 1996 |